Gilead Sciences (GILD) Misses Q1 EPS by 288c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $151.00 -0.15%
Revenue Growth %: -0.3%
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Income before provision for income taxes: 4.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - April 25, 2024 4:56 PM EDT)
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of ($1.32), $2.88 worse than the analyst estimate of $1.56. Revenue for the quarter came in at $6.65 billion versus the consensus estimate of $6.36 billion.
GUIDANCE:
Gilead Sciences sees FY2024 EPS of $3.45-$3.85, versus the consensus of $3.67.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
